This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

September 9, 2021
Delivered DigitallyUS Eastern Daylight Time

B-Side Pharma Ltd.

Profile

B-Side Pharma provides an innovative solution for multiple cancer types through JVB-14; a peptide with a novel mechanism of action which inhibits the Heparanase enzyme. B-Side’s intellectual property, experienced management team and unique mechanism of action puts it in a great position to help solve some of the deadliest cancer indications known today, starting from Triple Negative Breast Cancer (TNBC).